Status:

UNKNOWN

The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Tourette Syndrome

Lead Sponsor:

Beijing Pins Medical Co., Ltd

Collaborating Sponsors:

Beijing Tiantan Hospital

Conditions:

Tourette Syndrome

Eligibility:

All Genders

18+ years

Phase:

EARLY_PHASE1

Brief Summary

The purpose of this clinical study is to verify the long term effectiveness and safety of a bilateral deep brain stimulation (DBS) produced by Beijing PINS Medical Co., Ltd. as a treatment option for ...

Eligibility Criteria

Inclusion

  • Subject is aged 18 or older
  • Patient Group with Tourette's syndrome, Diagnosis of Tourette Syndrome by DSM-IV

Exclusion

  • Major Depressive Episode within the previous 6 months
  • Schizophrenia or other psychotic disorder.Participate in other clinical trial;
  • Has a life expectancy of \< 1 year.
  • The investigator and/or enrollment review committee, would preclude participation in the study.

Key Trial Info

Start Date :

December 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2018

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT02253498

Start Date

December 1 2016

End Date

December 1 2018

Last Update

October 14 2016

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Tourette Syndrome | DecenTrialz